secwatch.observer — SEC 8-K summary
======================================

Issuer:     Onconetix, Inc. (ONCO)
CIK:        0001782107
Form:       8-K
Filed at:   2023-06-06T23:59:59+00:00
Accession:  0001213900-23-046841
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 1.01, 5.02, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Blue Water Biotech adopts 401(k) plan, reduces stockholder quorum, and approves equity plan increase at annual meeting
--------------------------------------------------------------------------------

- Adopted 401(k) Safe Harbor Non-Elective Plan effective July 1, 2023; company contributes 3% of gross pay, immediate vesting.
- Bylaws amended to reduce stockholder quorum requirement from majority to one-third of voting power, effective immediately.
- Annual meeting results: James Sapirstein elected Class II director for three-year term; 6.2M votes for, 657K withheld.
- Amendment to 2022 Equity Incentive Plan approved, increasing authorized shares by 550,000 to 3,150,000 total.
- Ratified Mayer Hoffman McCann P.C. as independent auditor for fiscal year ending December 31, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1782107/000121390023046841/0001213900-23-046841-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1782107/000121390023046841/ea179858-8k_bluewater.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-046841

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer